The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention

Table 2

Distribution of TGFB1 and VEGFA polymorphism genotypes in the analyzed patient cohort ().

Gene/polymorphism	Homozygous major	Heterozygous	Homozygous minor	HWE value	MAF	MAF EU population [51]
	A/A	A/G	G/G
TGFB1 (rs1800470)	224 (33.8%)	310 (46.8%)	129 (19.5%)	0.27	42.8	38
	A/A	A/C	C/C
VEGFA (rs699947)	186 (27.6%)	322 (47.7%)	167 (24.7%)	0.25	48.6	50

Genotypes of TGFB1 and VEGFA were successfully established for 663 (98.1%) and 675 (99.9%) patients, respectively. MAF: minor allele frequency; EU: European Union; HWE: Hardy-Weinberg equilibrium.